Trial Profile
Clinical Trials Insight: 700005628
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 23 Aug 2023
Price :
$35
*
At a glance
- Drugs Aplaviroc (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 21 Oct 2005 New trial record.